Nsomniyak correct on both points. BP are in real serious situations with many of their patents expiring on major drugs in the near future, and the competition for outstanding potential new drugs is fierce. AUPH sure looks to be one of those biotechs on MANY BP radars! Exciting days ahead!
News 
Market Data 
Discover 
AI
